Journal
Annals of Clinical and Translational Neurology
Publication Date
12-1-2019
Volume
6
Issue
12
First Page
2555
Last Page
2565
Document Type
Open Access Publication
DOI
10.1002/acn3.50952
Rights and Permissions
Payne, J.M., Hearps, S.J.C., Walsh, K.S., Paltin, I., Barton, B., Ullrich, N.J., Haebich, K.M., Coghill, D., Gioia, G.A., Cantor, A., Cutter, G., Tonsgard, J.H., Viskochil, D., Rey‐Casserly, C., Schorry, E.K., Ackerson, J.D., Klesse, L., Fisher, M.J., Gutmann, D.H., Rosser, T., Packer, R.J., Korf, B., Acosta, M.T., North, K.N. and (2019), Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol, 6: 2555-2565. doi:10.1002/acn3.50952 © 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Recommended Citation
Payne, Jonathan M; Gutmann, David H; and et al, "Reproducibility of cognitive endpoints in clinical trials: Lessons from neurofibromatosis type 1." Annals of Clinical and Translational Neurology. 6, 12. 2555 - 2565. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8616
Table S1. Theoretical justifications for the confirmatory factor analysis model.
acn350952-sup-0002-tables2.docx (12 kB)
Table S2. Confirmatory factor analysis fit statistics.
